Doug E. Mager
Impact in
- Psychiatry and Mental health top 10%
- Attention Deficit Hyperactivity Disorder
- Schizophrenia research and treatment
- Epidemiology top 10%
- Substance Abuse Treatment and Outcomes
Papers in
-
- Schizophrenia research and treatment 4
-
- Substance Abuse Treatment and Outcomes 5
- Co-authors
- Bridget F. Grant (3 shared papers)Deborah S. Hasin (2 shared papers)Somnath Chatterji (2 shared papers)Radu Vrasti (2 shared papers)Wilson M. Compton (4 shared papers)Linda Bauer Cottler (3 shared papers)Emily Cox (3 shared papers)Brenda R. Motheral (3 shared papers)
- Journals
- Drug and Alcohol Dependence (4 papers)American Journal on Addictions (2 papers)European Addiction Research (2 papers)PEDIATRICS (1 paper)PubMed (2 papers)
- Partner nations
- United StatesIndiaLuxembourg
In The Last Decade
Doug E. Mager
11 papers receiving 868 citations
Peers
Comparison fields: 5 of 66
- Psychiatry and Mental health 161
- Epidemiology 327
- Clinical Psychology 202
- Pharmacology 95
- Toxicology 13
Countries citing papers authored by Doug E. Mager
This map shows the geographic impact of Doug E. Mager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug E. Mager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug E. Mager more than expected).
Fields of papers citing papers by Doug E. Mager
This network shows the impact of papers produced by Doug E. Mager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug E. Mager. The network helps show where Doug E. Mager may publish in the future.
Co-authors
The 23 scholars most cited alongside Doug E. Mager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 262 | |
| 2 | 1997 | 236 | |
| 3 | 2003 | 154 | |
| 4 | 1998 | 102 | |
| 5 | 1995 | 42 | |
| 6 | 1997 | 36 | |
| 7 | 1994 | 28 | |
| 8 | 1994 | 18 | |
| 9 | Prescribing COX-2s for patients new to cyclo-oxygenase inhibition therapy. | 2003 | 13 |
| 10 | Verification of a decision analytic model assumption using real-world practice data: implications for the cost effectiveness of cyclo-oxygenase 2 inhibitors (COX-2s). | 2003 | 8 |
| 11 | 1998 | 1 |
About Doug E. Mager
Doug E. Mager is a scholar working on Psychiatry and Mental health, Epidemiology, Cognitive Neuroscience, Pharmacology and Cellular and Molecular Neuroscience, having authored 11 papers that have together received 900 indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (5 papers), Schizophrenia research and treatment (4 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Sleep and Wakefulness Research (2 papers), Neuroethics, Human Enhancement, Biomedical Innovations (1 paper), Personality Disorders and Psychopathology (1 paper), Memory and Neural Mechanisms (1 paper) and Opioid Use Disorder Treatment (1 paper). The work is most often cited by research in Psychiatry and Mental health (161 citations), Epidemiology (327 citations), Clinical Psychology (202 citations), Pharmacology (95 citations) and Toxicology (13 citations). Doug E. Mager has collaborated with scholars based in United States, India and Luxembourg. Frequent co-authors include Bridget F. Grant, Deborah S. Hasin, Somnath Chatterji, Radu Vrasti, Wilson M. Compton, Linda Bauer Cottler, Emily Cox, Brenda R. Motheral, JOHN B. DEC. M. SAUNDERS and Rochelle R. Henderson. Their work appears in journals such as Drug and Alcohol Dependence, American Journal on Addictions, European Addiction Research, PEDIATRICS and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.